Skip to main content
Contact Us
Subscribe
E-Edition
84°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NTLA
Recent news which mentions NTLA
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Tickers
ABUS
ACAD
ADAP
AGIO
Tags
General
ACAD
ADAP
From
Benzinga
Recap: Intellia Therapeutics Q2 Earnings
August 04, 2022
Tickers
NTLA
Tags
Earnings
News
Benzinga
From
Benzinga
Why Are Gene Editing Stocks NTLA, ALNY, CRSP, BEAM Up Today?
August 03, 2022
Tickers
ALNY
ARKK
BEAM
CRSP
Tags
Market News
NASDAQ:ALNY,NASDAQ:CRSP,NASDAQ:BEAM,NASDAQ:NTLA,NYSEARCA:ARKK
NTLA
From
InvestorPlace
7 Cathie Wood Stocks Trading at a Discount Right Now
July 26, 2022
Tickers
ARKF
ARKG
ARKK
ARKQ
Tags
TDOC
MELI
NVS
From
InvestorPlace
Down 35% This Year, Is This Small-Cap Stock a Buy?
July 21, 2022
Tickers
BLUE
CRSP
EDIT
NTLA
Tags
VRTX
BLUE
NTLA
From
Motley Fool
Is It Time to Buy the Dip With Biotech Stocks?
July 21, 2022
Tickers
NTLA
XBI
Tags
Recent Press Releases
XBI
NTLA
From
Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
July 20, 2022
Tickers
AZN
AZTA
BEAM
CTIC
Tags
Benzinga
UNH
Options
From
Benzinga
2 Biotech Stocks You'll Regret Not Buying on the Dip
July 18, 2022
Tickers
BCRX
NTLA
Tags
Recent Press Releases
Market News
NTLA
From
Motley Fool
The 3 Leaders of the Gene Editing Revolution
July 08, 2022
Tickers
BEAM
BIIB
CRSP
EDIT
Tags
VRTX
Market Insight, Financial Articles
NTLA
From
InvestorPlace
7 Moonshot Investments Upending a $10 Trillion Industry
July 08, 2022
Tickers
AMZN
BEAM
BIIB
CRSP
Tags
EDIT
EBAY
AMZN
From
InvestorPlace
Up 1,000% in 5 Years? Here Are 3 Stocks That Can Run That High
June 25, 2022
Tickers
DOCS
NTLA
TMDX
Tags
TMDX
Recent Press Releases
DOCS
From
Motley Fool
Intellia's Gene-Editing Candidate Shows Durability In ATTR Amyloidosis
June 24, 2022
Tickers
NTLA
REGN
Tags
Health Care
General
REGN
From
Benzinga
BMO Initiates Coverage On This Gene Editing Spearhead
June 17, 2022
Tickers
EDIT
NTLA
Tags
NTLA
Analyst Ratings
Market News
From
Benzinga
Analyst Ratings for Intellia Therapeutics
June 16, 2022
Tickers
NTLA
Tags
Market News
Analyst Ratings
NTLA
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2022
June 16, 2022
Tickers
AIRS
AJG
APLE
AWI
Tags
RSG
Downgrades
APLE
From
Benzinga
Analyst Ratings for Intellia Therapeutics
May 24, 2022
Tickers
NTLA
Tags
Benzinga
BZI/AAR
NTLA
From
Benzinga
Why Editas Medicine's Shares Fell 28.9% This Week
May 13, 2022
Tickers
CRSP
EDIT
NTLA
Tags
^IXIC
CRSP
Recent Press Releases
From
Motley Fool
10 Biggest Price Target Changes For Monday
May 09, 2022
Tickers
CI
EPAM
GH
K
Tags
MCK
RLMD
Price Target Changes
From
Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Tickers
ABUS
AGIO
ALDX
ARGX
Tags
AXGN
VNDA
General
From
Benzinga
Earnings Preview For Intellia Therapeutics
May 04, 2022
Tickers
NTLA
Tags
Benzinga
Earnings
Market News
From
Benzinga
How To Attend Intellia Therapeutics Q1 2022 Earnings Conference Call
May 02, 2022
Tickers
NTLA
Tags
BZI/CONF
Benzinga
NTLA
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022
April 28, 2022
Tickers
ACHR
ALL
AM
ARVN
Tags
Analyst Ratings
ALL
SPOT
From
Benzinga
4 Analysts Have This to Say About Intellia Therapeutics
April 28, 2022
Tickers
NTLA
Tags
Analyst Ratings
Market News
NTLA
From
Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 21, 2022
Tickers
HLBZ
HNST
HYFM
HYRE
Tags
WPRT
RMBL
ONCR
From
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
Tickers
ACLX
ADVM
AFCG
ALLK
Tags
EHTH
IAC
BMEA
From
Benzinga
3 Top Biotech Stocks Ready for a Bull Run
April 20, 2022
Tickers
BNTX
NTLA
PFE
REGN
Tags
PFE
NTLA
Market News
From
Motley Fool
3 Ominous Reasons to Avoid This Biotech Pioneer
April 19, 2022
Tickers
CRSP
EDIT
NTLA
Tags
EDIT
NTLA
Market News
From
Motley Fool
CRISPR Stocks Are Huge -- Here's Why They'll Get Even Bigger by 2030
April 13, 2022
Tickers
CRSP
EDIT
NTLA
VRTX
Tags
Market News
NTLA
EDIT
From
Motley Fool
Who Benefits From Amazon's Stock Split?
March 16, 2022
Tickers
AAPL
AMZN
BMBL
CMG
Tags
GS
ONT
Recent Press Releases
From
Motley Fool
FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
March 15, 2022
Tickers
BLUE
NTLA
Tags
BLUE
Gene Editing
General
From
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.